Overall, this study identified that AR was frequently expressed in Xp11.2 tRCC tissues and that the expression of AR was associated with patient PFS. The gene discussed is AR; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.